Related references
Note: Only part of the references are listed.Ribophorin II regulates breast tumor initiation and metastasis through the functional suppression of GSK3β
Ryou-u Takahashi et al.
SCIENTIFIC REPORTS (2013)
Pulmonary delivery of therapeutic siRNA
Jenny Ka-Wing Lam et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
RPN2 expression predicts response to docetaxel in oesophageal squamous cell carcinoma
J. Kurashige et al.
BRITISH JOURNAL OF CANCER (2012)
RNA-Based Therapeutics: Current Progress and Future Prospects
John C. Burnett et al.
CHEMISTRY & BIOLOGY (2012)
Identification of Glycoprotein Markers for Pancreatic Cancer CD24+CD44+ Stem-like Cells Using Nano-LC-MS/MS and Tissue Microarray
Jianhui Zhu et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
Julian R. Molina et al.
MAYO CLINIC PROCEEDINGS (2012)
Efficacy of a Novel Class of RNA Interference Therapeutic Agents
Tomohiro Hamasaki et al.
PLOS ONE (2012)
Current Progress of RNA Aptamer-Based Therapeutics
Jiehua Zhou et al.
Frontiers in Genetics (2012)
Lung Cancer: New Biological Insights and Recent Therapeutic Advances
Suresh S. Ramalingam et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Promise and Challenge of RNA Interference-Based Therapy for Cancer
Fabio Petrocca et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
New driver mutations in non-small-cell lung cancer
William Pao et al.
LANCET ONCOLOGY (2011)
Current prospects for RNA interference-based therapies
Beverly L. Davidson et al.
NATURE REVIEWS GENETICS (2011)
RNA interference in the clinic: challenges and future directions
Chad V. Pecot et al.
NATURE REVIEWS CANCER (2011)
Fluorescent Indicators for Intracellular pH
Junyan Han et al.
CHEMICAL REVIEWS (2010)
RNAi and small interfering RNAs in human disease therapeutic applications
Monica R. Lares et al.
TRENDS IN BIOTECHNOLOGY (2010)
Systemic Delivery and Quantification of Unformulated Interfering RNAs In Vivo
Aurelie Morin et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
RPN2 gene confers docetaxel resistance in breast cancer
Kimi Honma et al.
NATURE MEDICINE (2008)
Molecular origins of cancer: Lung cancer
Roy S. Herbst et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Strategies for silencing human disease using RNA interference
Daniel H. Kim et al.
NATURE REVIEWS GENETICS (2007)
siRNA and isRNA: Two edges of one sword
Martin Schlee et al.
MOLECULAR THERAPY (2006)
Therapeutic potential of RNA interference against cancer
Fumitaka Takeshita et al.
CANCER SCIENCE (2006)
Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes
C Matranga et al.
CELL (2005)
Non-invasive pulmonary aerosol delivery in mice by the endotracheal route
M Bivas-Benita et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2005)
Lack of interferon response in animals to naked siRNAs
JD Heidel et al.
NATURE BIOTECHNOLOGY (2004)
Share Paper
